Temat: "Dipeptidyl-Peptidase IV Inhibitors" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study.
Autorzy:: Gallego-Tamayo B; Universidad de Alcalá, Departamento de Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Campus Universitario, Crtra A2, Km. 33,600, 28805 Alcalá de Henares, Spain.
Santos-Aparicio Á; Universidad de Alcalá, Departamento de Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Campus Universitario, Crtra A2, Km. 33,600, 28805 Alcalá de Henares, Spain.
Yago-Ibáñez J; Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
Muñoz-Moreno L; Universidad de Alcalá, Departamento de Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Campus Universitario, Crtra A2, Km. 33,600, 28805 Alcalá de Henares, Spain.
Lucio-Cazaña FJ; Universidad de Alcalá, Departamento de Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Campus Universitario, Crtra A2, Km. 33,600, 28805 Alcalá de Henares, Spain.
Fernández-Martínez AB; Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 15; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus*/drug therapy
Acute Kidney Injury*/drug therapy
Acute Kidney Injury*/etiology
Acute Kidney Injury*/prevention & control
Dipeptidyl-Peptidase IV Inhibitors*/pharmacology
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Humans ; Cyclooxygenase 2/metabolism ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases ; Prostaglandins ; Dipeptidyl Peptidase 4

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Dipeptidyl peptidase-4 inhibition targeting vascular senescence as a novel treatment for atherosclerosis.
Autorzy:: Yen IW; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
Li HY; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Pokaż więcej
Źródło:: Journal of diabetes investigation [J Diabetes Investig] 2024 Feb; Vol. 15 (2), pp. 143-144. Date of Electronic Publication: 2023 Oct 20.
Typ publikacji:: Journal Article
MeSH Terms:: Atherosclerosis*/drug therapy
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Dipeptidyl-Peptidase IV Inhibitors*/pharmacology
Humans ; Dipeptidyl Peptidase 4

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy.
Autorzy:: Dimnjaković J; Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, Rockefeller's Street 7, 10 000, Zagreb, Croatia.
Buble T; Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, Rockefeller's Street 7, 10 000, Zagreb, Croatia.
Ivanko P; Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, Rockefeller's Street 7, 10 000, Zagreb, Croatia.
Pristaš I; Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, Rockefeller's Street 7, 10 000, Zagreb, Croatia.
Brborović O; School of Medicine, Andrija Štampar School of Public Health, Department of Social Medicine and Health Care Organization, University of Zagreb, Rockefeller's Street 4, 10 000, Zagreb, Croatia. .
Brborović H; School of Medicine, Andrija Štampar School of Public Health, Department of Environmental and Occupational Health and Sports Medicine, University of Zagreb, Rockefeller's Street 4, 10 000, Zagreb, Croatia.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7227. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
COVID-19*/complications
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Cardiomyopathies*/chemically induced
Humans ; Hypoglycemic Agents/therapeutic use ; Retrospective Studies ; COVID-19 Vaccines/therapeutic use ; SARS-CoV-2 ; Sulfonylurea Compounds/therapeutic use ; Insulin/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Computational Modeling of the Interactions between DPP IV and Hemorphins.
Autorzy:: Antony P; Department of Biology, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Baby B; Department of Biology, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Jobe A; Department of Biology, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Vijayan R; Department of Biology, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.; The Big Data Analytics Center, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.; Zayed Center for Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 06; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*
Dipeptidyl-Peptidase IV Inhibitors*/pharmacology
Humans ; Molecular Docking Simulation ; Dipeptidyl Peptidase 4/metabolism ; Peptides/chemistry ; Insulin ; Molecular Dynamics Simulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats.
Autorzy:: Łupina M; Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego 8b St., 20-090 Lublin, Poland.
Wąsik A; Department of Neurochemistry, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.
Baranowska-Bosiacka I; Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Powstańców Wlkp. 72 Av., 70-111 Szczecin, Poland.
Tarnowski M; Department of Physiology in Health Sciences, Pomeranian Medical University, Żołnierska 54, 70-210 Szczecin, Poland.
Słowik T; Experimental Medicine Center, Medical University of Lublin, Jaczewskiego 8d St., 20-090 Lublin, Poland.
Listos P; Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Life Sciences, Głęboka 30, 20-612 Lublin, Poland.
Kotlińska J; Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Chodźki 4a St., 20-093 Lublin, Poland.
Kosik-Bogacka D; Independent Laboratory of Pharmaceutical Botany, Department of Biology and Medical Parasitology, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Gutowska I; Department of Biochemistry and Human Nutrition, Pomeranian Medical University, Broniewskiego 24, 71-460 Szczecin, Poland.
Listos J; Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Chodźki 4a St., 20-093 Lublin, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 05; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Journal Article
MeSH Terms:: Linagliptin*/pharmacology
Dipeptidyl-Peptidase IV Inhibitors*/pharmacology
Rats ; Animals ; Serotonin ; Dopamine ; Norepinephrine ; Dipeptidyl Peptidase 4/metabolism ; Hippocampus/metabolism ; Neurotransmitter Agents ; RNA, Messenger

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Impact of treatment with GLP-1RAs on suicide attempts in adults persons with type 2 diabetes: A retrospective comparative effectiveness study based on a global TriNetX health research database.
Autorzy:: Nassar M; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Misra A; Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Diabetes Foundation (India), and National Diabetes Obesity and Cholesterol Foundation (NDOC), New Delhi, India.
Bloomgarden Z; Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Pokaż więcej
Źródło:: Journal of diabetes [J Diabetes] 2024 Mar; Vol. 16 (3), pp. e13547.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/epidemiology
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Adult ; Humans ; United States/epidemiology ; Retrospective Studies ; Suicide, Attempted ; Prospective Studies ; Hypoglycemic Agents/therapeutic use ; Glucagon-Like Peptide-1 Receptor/agonists

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis.
Autorzy:: Kashiwagi A; Department of Diabetes and Endocrinology, Omi Medical Center, Kusatsu, Shiga, Japan.
Shoji S; Medical Affairs, Astellas Pharma Inc., Tokyo, Japan.
Kosakai Y; Medical Affairs, Astellas Pharma Inc., Tokyo, Japan.
Yoshinaga Y; Data Science, Astellas Pharma Inc., Tokyo, Japan.
Rokuda M; Medical Affairs, Astellas Pharma Inc., Tokyo, Japan.; Pokaż więcej
Źródło:: Journal of diabetes investigation [J Diabetes Investig] 2024 Mar; Vol. 15 (3), pp. 374-387. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:: Journal Article
MeSH Terms:: Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Diabetes Mellitus, Type 2*/drug therapy
Humans ; Japan/epidemiology ; Retrospective Studies ; Health Care Costs ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases ; Glucose ; Sodium

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Autorzy:: Kamrul-Hasan ABM; Department of Endocrinology, Mymensingh Medical College, Mymensingh, Bangladesh.
Alam MS; Department of Medicine, Army Medical College Cumilla, Cumilla, Bangladesh.
Talukder SK; Department of Endocrinology, Rangpur Medical College, Rangpur, Bangladesh.
Dutta D; Department of Endocrinology, Center for Endocrinology, Diabetes, Arthritis and Rheumatism (CEDAR) Superspeciality Healthcare, New Delhi, India.
Selim S; Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.; Pokaż więcej
Źródło:: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Feb; Vol. 39 (1), pp. 109-126. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Dipeptidyl-Peptidase IV Inhibitors*/adverse effects
Diabetes Mellitus, Type 2*/complications
Hypoglycemia*/chemically induced
Hypoglycemia*/epidemiology
Heterocyclic Compounds, 2-Ring*
Pyrans*
Humans ; Glycated Hemoglobin ; Blood Glucose/analysis ; Hypoglycemic Agents/adverse effects ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus.
Autorzy:: Meng J; Department of Pathology, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Yan R; Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhang C; National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Bai X; Department of Hemotology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yang X; Department of Cardiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yang Y; Department of Cardiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Feng T; Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. .; National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. .
Liu X; Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. .; Pokaż więcej
Źródło:: Lipids in health and disease [Lipids Health Dis] 2023 Dec 11; Vol. 22 (1), pp. 219. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:: Systematic Review; Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Dipeptidyl-Peptidase IV Inhibitors*/pharmacology
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Cognitive Dysfunction*/drug therapy
Humans ; Activities of Daily Living ; Hypoglycemic Agents/therapeutic use ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion.
Autorzy:: Sodum N; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.
Mattila O; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.
Sharma R; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.
Kamakura R; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.
Lehto VP; Department of Technical Physics, Faculty of Science, Forestry and Technology, University of Eastern Finland, 70210 Kuopio, Finland.
Walkowiak J; Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, 60572 Poznań, Poland.
Herzig KH; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.; Department of Gastroenterology and Metabolism, Poznan University of Medical Sciences, 60572 Poznań, Poland.
Raza GS; Research Unit of Biomedicine and Internal Medicine, Biocentre of Oulu, Medical Research Center, University of Oulu, Oulu University Hospital, Aapistie 5, 90220 Oulu, Finland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 16; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:: Journal Article
MeSH Terms:: Amino Acids*
Dipeptidyl-Peptidase IV Inhibitors*
Humans ; Animals ; Mice ; L Cells ; Tryptophan ; Antiviral Agents ; Glucagon-Like Peptide 1/pharmacology ; Hypoglycemic Agents ; Nutrients ; Obesity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Study on the Mechanism of Interaction between Dipeptidyl Peptidase 4 and Inhibitory Peptides Based on Gaussian Accelerated Molecular Dynamic Simulation.
Autorzy:: Liu Y; Edmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun 130012, China.
Zhao W; Edmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun 130012, China.
Jiang Y; Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.
Xing S; Edmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun 130012, China.
Li W; Edmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun 130012, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 10; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*
Dipeptidyl-Peptidase IV Inhibitors*/pharmacology
Humans ; Dipeptidyl Peptidase 4 ; Molecular Dynamics Simulation ; Peptides/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Use of dipeptidyl peptidase-4 inhibitors was associated with a lower risk of Parkinson's disease in diabetic patients.
Autorzy:: Lin YH; Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, 1650 Taiwan Boulevard Sect. 4, Taichung, 40705, Taiwan.
Hsu CC; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.; National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan.; Department of Family Medicine, Min-Sheng General Hospital, Taoyuan, 33044, Taiwan.
Liu JS; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli, 35053, Taiwan.; National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan.
Chang KC; Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, 1650 Taiwan Boulevard Sect. 4, Taichung, 40705, Taiwan. .
Huang JA; Division of Neurology, Neurological Institute, Taichung Veterans General Hospital, 1650 Taiwan Boulevard Sect. 4, Taichung, 40705, Taiwan. .; Department of Health Business Administration, Hungkuang University, Taichung, 43302, Taiwan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Dec 15; Vol. 13 (1), pp. 22489. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:: Journal Article
MeSH Terms:: Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Parkinson Disease*/drug therapy
Parkinson Disease*/epidemiology
Parkinson Disease*/complications
Metformin*/therapeutic use
Humans ; Cohort Studies ; Hypoglycemic Agents/therapeutic use ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases ; Dipeptidyl Peptidase 4

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Tetrazoles and Related Heterocycles as Promising Synthetic Antidiabetic Agents.
Autorzy:: Trifonov RE; Department of Chemistry and Technology of Nitrogen-Containing Organic Compounds, Saint Petersburg State Institute of Technology (Technical University), St. Petersburg 190013, Russia.
Ostrovskii VA; Department of Chemistry and Technology of Nitrogen-Containing Organic Compounds, Saint Petersburg State Institute of Technology (Technical University), St. Petersburg 190013, Russia.; Saint Petersburg Federal Research Center of the Russian Academy of Sciences (SPC RAS), St. Petersburg 199178, Russia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 06; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Diabetes Mellitus, Type 2*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Humans ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use ; Tetrazoles/pharmacology ; Tetrazoles/therapeutic use ; Glucagon-Like Peptide-1 Receptor/agonists

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes.
Autorzy:: Ishibashi R; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Hirayama K; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
Watanabe S; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Okano K; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Kuroda Y; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Baba Y; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
Kanayama T; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
Ito C; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
Kasahara K; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
Aiba S; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
Iga R; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
Ohtani R; Department of Medicine, Division of Neurology, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
Inaba Y; Clinical Research Center, Chiba University Hospital, Chiba, Japan.
Koshizaka M; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Maezawa Y; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Yokote K; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.; Pokaż więcej
Źródło:: Journal of diabetes investigation [J Diabetes Investig] 2023 Dec; Vol. 14 (12), pp. 1419-1422. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:: Case Reports
MeSH Terms:: Diabetes Mellitus, Type 2*
Deafness*/drug therapy
Deafness*/chemically induced
Dipeptidyl-Peptidase IV Inhibitors*/adverse effects
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Female ; Humans ; Middle Aged ; Blood Glucose/analysis ; Glucagon ; Glycemic Control ; Maternal Inheritance ; Hypoglycemic Agents/therapeutic use

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Predictors of HbA 1c treatment response to add-on medication following metformin monotherapy: a population-based cohort study.
Autorzy:: Tan WY; Saw Swee Hock School of Public Health, National University of Singapore, MD1 - Tahir Foundation Building, 12 Science Drive 2, #11, Singapore, 117549, Singapore. .
Hsu W; Institute of Data Science, National University of Singapore, Singapore, Singapore.; School of Computing, National University of Singapore, Singapore, Singapore.
Lee ML; Institute of Data Science, National University of Singapore, Singapore, Singapore.; School of Computing, National University of Singapore, Singapore, Singapore.
Tan NC; SingHealth Polyclinics, SingHealth, Singapore, Singapore.; Family Medicine Academic Clinical Programme, SingHealth-Duke NUS Academic Medical Centre, Singapore, Singapore.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 28; Vol. 13 (1), pp. 20891. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:: Journal Article
MeSH Terms:: Metformin*/pharmacology
Diabetes Mellitus, Type 2*/complications
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Hypertension*/complications
Adult ; Humans ; Hypoglycemic Agents/pharmacology ; Cohort Studies ; Retrospective Studies ; Creatinine/therapeutic use ; Drug Therapy, Combination ; Sulfonylurea Compounds/adverse effects ; Angiotensins ; Cholesterol/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.
Autorzy:: de Nicolas-Ruanes B; Dermatology Department, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.
Ballester-Martinez A; Dermatology Department, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.
Garcia-Mouronte E; Dermatology Department, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.
Berna-Rico E; Dermatology Department, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.
Azcarraga-Llobet C; Dermatology Department, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.
Fernandez-Guarino M; Dermatology Department, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 26; Vol. 24 (23). Date of Electronic Publication: 2023 Nov 26.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Pemphigoid, Bullous*/chemically induced
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Autoimmune Diseases*
Humans ; Autoantigens ; Autoantibodies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Association between hypoglycemic agent use and the risk of occurrence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Autorzy:: Jung C; College of Pharmacy, Sookmyung Women's University, Seoul, Republic of Korea.
Park S; College of Pharmacy, Sookmyung Women's University, Seoul, Republic of Korea.
Kim H; College of Pharmacy, Sookmyung Women's University, Seoul, Republic of Korea.; Drug Information Research Institute, Sookmyung Women's University, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Nov 22; Vol. 18 (11), pp. e0294423. Date of Electronic Publication: 2023 Nov 22 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/chemically induced
Sodium-Glucose Transporter 2 Inhibitors*/adverse effects
Dipeptidyl-Peptidase IV Inhibitors*/adverse effects
Humans ; Hypoglycemic Agents/adverse effects ; Cohort Studies ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease.
Autorzy:: Tan X; Novo Nordisk Inc., Plainsboro, NJ, USA.
Liang Y; Novo Nordisk Inc., Plainsboro, NJ, USA.
Rajpura JR; Novo Nordisk Inc., Plainsboro, NJ, USA.
Yedigarova L; Novo Nordisk Inc., Plainsboro, NJ, USA.
Noone J; Novo Nordisk Inc., Plainsboro, NJ, USA.
Xie L; Novo Nordisk Inc., Plainsboro, NJ, USA.
Inzucchi S; Department of Endocrinology, Yale University, New Haven, CT, USA.
de Havenon A; Department of Neurology, Center for Brain and Mind Health, Yale School of Medicine, Yale University, 15 York St, New Haven, CT, 06510, USA. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Nov 20; Vol. 22 (1), pp. 319. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:: Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Dipeptidyl-Peptidase IV Inhibitors*/adverse effects
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Cardiovascular Diseases*/diagnosis
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/prevention & control
Myocardial Infarction*/diagnosis
Myocardial Infarction*/epidemiology
Myocardial Infarction*/complications
Ischemic Stroke*
Adult ; Humans ; Glucagon-Like Peptide-1 Receptor/agonists ; Risk Factors ; Glucagon-Like Peptide 1/therapeutic use ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/therapeutic use ; Hypoglycemic Agents/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Effect of dipeptidyl peptidase-4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus.
Autorzy:: Choi Y; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.; Cardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Ko SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Chang K; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.; Cardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Yoo KD; Cardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, South Korea.; Division of Cardiology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Ihm SH; Cardiovascular Research Institute for Intractable Disease, College of Medicine, The Catholic University of Korea, Seoul, South Korea.; Division of Cardiology, Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.; Pokaż więcej
Źródło:: Journal of diabetes [J Diabetes] 2023 Nov; Vol. 15 (11), pp. 944-954. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/epidemiology
Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
Coronary Artery Disease*/diagnostic imaging
Coronary Artery Disease*/drug therapy
Humans ; Insulin/therapeutic use ; Hypoglycemic Agents/therapeutic use ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/therapeutic use ; Tomography

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Integration of Deep Learning and Sequential Metabolism to Rapidly Screen Dipeptidyl Peptidase (DPP)-IV Inhibitors from Gardenia jasminoides Ellis .
Autorzy:: Liu H; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Yu S; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Li X; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Wang X; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Qi D; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Pan F; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Chai X; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Wang Q; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Pan Y; Institute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Zhang L; Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.
Liu Y; School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Nov 01; Vol. 28 (21). Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:: Journal Article
MeSH Terms:: Dipeptidyl-Peptidase IV Inhibitors*/pharmacology
Gardenia*/chemistry
Deep Learning*
Iridoid Glycosides/chemistry ; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases ; Dipeptidyl Peptidase 4 ; Molecular Docking Simulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Dipeptidyl-Peptidase IV Inhibitors"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język